Cliniqa Corporation

Founded in 1981, Neurosciences Research Foundation is an independent nonprofit scientific research organization that undertakes various activities related to functioning of human brain in health issues and diseases. The organization conducts investigations in a range of areas of neuroscience that includes modeling of brain, spatial navigation, developmental neurobiology, auditory cortex and neuronal plasticity. Neurosciences Research Foundation s board of trustees includes representatives of the general public, as well as scientists. The organization is supported by gifts and grants from nongovernmental agencies, including individuals, foundations and corporations. Neurosciences Research Foundation is located in San Diego.

Laborers International Union in San Marcos is a part of the Build America union, representing over half a million members dedicated to advocating for improved wages and benefits. The union is committed to promoting safer job sites and creating greater opportunities for its members in the construction industry. Generated from their website's infomation

AutoGenomics, based in Vista, CA, is a leading provider of fully integrated systems for clinical laboratories, offering a wide range of automated, cost-effective, and user-friendly tests with exceptional accuracy and sensitivity. Their INFINITI system, designed specifically for their proprietary BioFilmChip microarrays, allows for multiplexing and configuration with hundreds of biomarkers, enabling the assessment of disease signatures from a single sample specimen. With a focus on empowering healthcare professionals, AutoGenomics aims to uncover critical insights that enhance patient care and prevention, utilizing their expertise in various fields to develop powerful tests, instruments, and analytics that provide actionable results for more informed decision-making. AutoGenomics is dedicated to revolutionizing healthcare by providing clinical laboratories with advanced technologies that improve productivity, workflow, and cost per reportable result. Their comprehensive approach, combining expertise in pharmacology, chemistry, pathology, pharmacogenomics, and toxicology, enables the delivery of accurate and timely information to physicians, allowing for better prescription choices and predictions of patient reactions to potential treatments. With a strong commitment to innovation and a focus on the future, AutoGenomics is poised to shape the next frontier in healthcare, addressing critical needs with their ready-to-use technology and unwavering passion.Generated from the website